- Home
- Publications
- Publication Search
- Publication Details
Title
GM1 Gangliosidosis—A Mini-Review
Authors
Keywords
-
Journal
Frontiers in Genetics
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-09-04
DOI
10.3389/fgene.2021.734878
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A GM1 gangliosidosis mutant mouse model exhibits activated microglia and disturbed autophagy
- (2021) Sichi Liu et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Disentangling molecular and clinical stratification patterns in beta-galactosidase deficiency
- (2021) Abdellah Tebani et al. JOURNAL OF MEDICAL GENETICS
- Structure of the murine lysosomal multienzyme complex core
- (2021) Alexei Gorelik et al. Science Advances
- Lysosomal storage disorders as an etiology of nonimmune hydrops fetalis: A systematic review
- (2021) Neel S. Iyer et al. CLINICAL GENETICS
- Examination of a blood-brain barrier targeting β-galactosidase-monoclonal antibody fusion protein in a murine model of GM1-gangliosidosis
- (2021) Michael J. Przybilla et al. Molecular Genetics and Metabolism Reports
- Axonopathy and Reduction of Membrane Resistance: Key Features in a New Murine Model of Human GM1-Gangliosidosis
- (2020) Deborah Eikelberg et al. Journal of Clinical Medicine
- Substrate reduction therapy with Miglustat in pediatric patients with GM1 type 2 gangliosidosis delays neurological involvement: A multicenter experience
- (2020) Rita Fischetto et al. Molecular Genetics & Genomic Medicine
- A single injection of an optimized AAV vector into cerebrospinal fluid corrects neurological disease in a murine model of GM1 gangliosidosis
- (2020) Christian Hinderer et al. HUMAN GENE THERAPY
- Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Oral Venglustat in Healthy Volunteers
- (2020) M. Judith Peterschmitt et al. Clinical Pharmacology in Drug Development
- Lysosomal Glycosphingolipid Storage Diseases
- (2019) Bernadette Breiden et al. Annual Review of Biochemistry
- Intracerebroventricular enzyme replacement therapy with Beta-Galactosidase reverses brain pathologies due to GM1 gangliosidosis in mice
- (2019) Joseph C Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pre-diagnosing and managing patients with GM1 gangliosidosis and related disorders by the evaluation of GM1 ganglioside content
- (2019) Rodolfo Tonin et al. Scientific Reports
- The skeletal phenotype of intermediate GM1 gangliosidosis: Clinical, radiographic and densitometric features, and implications for clinical monitoring and intervention
- (2019) Carlos R. Ferreira et al. BONE
- The Clinical and Molecular Spectrum of GM1 Gangliosidosis
- (2019) Laila Arash-Kaps et al. JOURNAL OF PEDIATRICS
- The natural history of Type 1 infantile GM1 gangliosidosis: A literature-based meta-analysis
- (2019) Frederick M. Lang et al. MOLECULAR GENETICS AND METABOLISM
- 7T MRI Predicts Amelioration of Neurodegeneration in the Brain after AAV Gene Therapy
- (2019) Heather L. Gray-Edwards et al. Molecular Therapy-Methods & Clinical Development
- Mitochondria-associated ER membranes (MAMs) and lysosomal storage diseases
- (2018) Ida Annunziata et al. Cell Death & Disease
- Comprehensive behavioral and biochemical outcomes of novel murine models of GM1-gangliosidosis and Morquio syndrome type B
- (2018) Michael J. Przybilla et al. MOLECULAR GENETICS AND METABOLISM
- Lysosomal storage diseases
- (2018) Frances M. Platt et al. Nature Reviews Disease Primers
- (5a R )-5a- C- Pentyl-4- epi -isofagomine: A powerful inhibitor of lysosomal β-galactosidase and a remarkable chaperone for mutations associated with GM1-gangliosidosis and Morquio disease type B
- (2017) Sophie Front et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The treatment of juvenile/adult GM1-gangliosidosis with Miglustat may reverse disease progression
- (2017) Federica Deodato et al. METABOLIC BRAIN DISEASE
- Infantile gangliosidoses: Mapping a timeline of clinical changes
- (2017) Jeanine R. Jarnes Utz et al. MOLECULAR GENETICS AND METABOLISM
- Novel Biomarkers of Human GM1 Gangliosidosis Reflect the Clinical Efficacy of Gene Therapy in a Feline Model
- (2017) Heather L. Gray-Edwards et al. MOLECULAR THERAPY
- Duvoglustat HCl Increases Systemic and Tissue Exposure of Active Acid α-Glucosidase in Pompe Patients Co-administered with Alglucosidase α
- (2017) Priya Kishnani et al. MOLECULAR THERAPY
- Polyethylene glycol-b-poly(lactic acid) polymersomes as vehicles for enzyme replacement therapy
- (2017) Jessica M Kelly et al. Nanomedicine
- ClinVar: improving access to variant interpretations and supporting evidence
- (2017) Melissa J Landrum et al. NUCLEIC ACIDS RESEARCH
- Development of a new tandem mass spectrometry method for urine and amniotic fluid screening of oligosaccharidoses
- (2017) Monique Piraud et al. RAPID COMMUNICATIONS IN MASS SPECTROMETRY
- Lipidomic Evaluation of Feline Neurologic Disease after AAV Gene Therapy
- (2017) Heather L. Gray-Edwards et al. Molecular Therapy-Methods & Clinical Development
- Synthesis of C-5a-chain extended derivatives of 4-epi-isofagomine: Powerful β-galactosidase inhibitors and low concentration activators of GM1-gangliosidosis-related human lysosomal β-galactosidase
- (2016) Martin Thonhofer et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Enzyme replacement for GM1-gangliosidosis: Uptake, lysosomal activation, and cellular disease correction using a novel β-galactosidase:RTB lectin fusion
- (2016) Jose Condori et al. MOLECULAR GENETICS AND METABOLISM
- Review of miglustat for clinical management in Gaucher disease type 1
- (2016) Can Ficicioglu Therapeutics and Clinical Risk Management
- MRI/MRS as a surrogate marker for clinical progression in GM1 gangliosidosis
- (2015) Debra S. Regier et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Systemic AAV9 gene transfer in adult GM1 gangliosidosis mice reduces lysosomal storage in CNS and extends lifespan
- (2015) Cara M. Weismann et al. HUMAN MOLECULAR GENETICS
- Pharmacological Chaperone Therapy: Preclinical Development, Clinical Translation, and Prospects for the Treatment of Lysosomal Storage Disorders
- (2015) Giancarlo Parenti et al. MOLECULAR THERAPY
- The multi-tasked life of GM1 ganglioside, a true factotum of nature
- (2015) Robert W. Ledeen et al. TRENDS IN BIOCHEMICAL SCIENCES
- Emerging novel concept of chaperone therapies for protein misfolding diseases
- (2014) Yoshiyuki SUZUKI PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Sustained Normalization of Neurological Disease after Intracranial Gene Therapy in a Feline Model
- (2014) V. J. McCurdy et al. Science Translational Medicine
- Lysosomal multienzyme complex: pros and cons of working together
- (2013) Erik J. Bonten et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- A Bicyclic 1-Deoxygalactonojirimycin Derivative as a Novel Pharmacological Chaperone for GM1 Gangliosidosis
- (2013) Tomoko Takai et al. MOLECULAR THERAPY
- Analysis of urinary oligosaccharides in lysosomal storage disorders by capillary high-performance anion-exchange chromatography–mass spectrometry
- (2012) Cees Bruggink et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Therapeutic chaperone effect of N-Octyl 4-Epi-β-valienamine on murine GM1-gangliosidosis
- (2012) Yoshiyuki Suzuki et al. MOLECULAR GENETICS AND METABOLISM
- GM1 gangliosidosis and Morquio B disease: An update on genetic alterations and clinical findings
- (2011) Anna Caciotti et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Crystal Structure of Human β-Galactosidase
- (2011) Umeharu Ohto et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- DLHex-DGJ, a novel derivative of 1-deoxygalactonojirimycin with pharmacological chaperone activity in human GM1-gangliosidosis fibroblasts
- (2010) Katrin Fantur et al. MOLECULAR GENETICS AND METABOLISM
- AAV-Mediated Gene Delivery in Adult GM1-Gangliosidosis Mice Corrects Lysosomal Storage in CNS and Improves Survival
- (2010) Rena C. Baek et al. PLoS One
- Intracerebral cell transplantation therapy for murine GM1 gangliosidosis
- (2009) Tomo Sawada et al. BRAIN & DEVELOPMENT
- Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics
- (2009) Giancarlo Parenti EMBO Molecular Medicine
- Structural bases of GM1 gangliosidosis and Morquio B disease
- (2009) Mizuki Morita et al. JOURNAL OF HUMAN GENETICS
- GM1-Ganglioside Accumulation at the Mitochondria-Associated ER Membranes Links ER Stress to Ca2+-Dependent Mitochondrial Apoptosis
- (2009) Renata Sano et al. MOLECULAR CELL
- Chemical chaperone therapy for GM1-gangliosidosis
- (2008) Y. Suzuki CELLULAR AND MOLECULAR LIFE SCIENCES
- Lysosomal Storage Diseases and the Blood-Brain Barrier
- (2008) David Begley et al. CURRENT PHARMACEUTICAL DESIGN
- Mechanisms of distribution of mouse β-galactosidase in the adult GM1-gangliosidosis brain
- (2008) M L D Broekman et al. GENE THERAPY
- Generation and characterization of recombinant feline β-galactosidase for preclinical enzyme replacement therapy studies in GM1 gangliosidosis
- (2008) Tatiana I. Samoylova et al. METABOLIC BRAIN DISEASE
- Beneficial effects of substrate reduction therapy in a mouse model of GM1 gangliosidosis
- (2008) Elena Elliot-Smith et al. MOLECULAR GENETICS AND METABOLISM
- GM1 gangliosidosis: Review of clinical, molecular, and therapeutic aspects
- (2008) Nicola Brunetti-Pierri et al. MOLECULAR GENETICS AND METABOLISM
- New GLB1 mutation in siblings with Morquio type B disease presenting with mental regression
- (2008) Fabiana Quoos Mayer et al. MOLECULAR GENETICS AND METABOLISM
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started